ICON Reports Fourth Quarter 2013 Revenue Of $345 Million, Up 15% Year On Year And EPS Of 53c, Up 56% Year On Year. Full Year 2013 Revenue Was $1.34 Billion, Up 20% Year On Year, EPS Was $1.77 Up 77% Year On Year. Guidance Issued For 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ICON plc, (NASDAQ:ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the full year and fourth quarter ended December 31, 2013.

For the fourth quarter net revenue grew 15% year on year to $345 million. Operating income was $38.7 million compared to $24.4 million in the same quarter last year. Operating margin was 11.2% of revenue, compared to 8.1% of revenue for the same quarter last year.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC